A series of 36 phenoxypropanolamines was examined to determine the structure–activity relationships of β-adrenoceptor (β-AR) antagonists for the human β 1-AR. The binding affinities of all the compounds were determined for human β 1-ARs expressed in Chinese hamster ovary cells and the antagonist potency for rat atrial β 1-ARs was determined for 32 of these compounds for comparative purposes. The compounds, based upon a phenoxypropanolamine core structure with various meta-, ortho-, para- and amine-substituents, displayed binding affinities (p K i) for the human β 1-AR ranging from 5.49 to 9.35. Antagonist potencies (p A 2) in the rat ranged from 5.52 to 9.56 and correlated with the human binding affinities ( r 2=0.86). Twenty-six compounds were used as the training set for comparative molecular field analysis (CoMFA) of antagonist binding affinity at the human β 1-AR and also of antagonist potency for rat atrial β 1-ARs. The CoMFA models were derived using both the CoMFA electrostatic and steric field parameters. The initial human β 1-AR model ( n=26, q 2=0.59, ONC=6, SE CV=0.70, r 2=0.98, SE non-CV=0.16, F(6, 19)=148) predicted the binding affinities of seven out of ten test compounds, not included in the training set, with residual p K i values ≤0.50. The final human β 1-AR model ( n=36, q 2=0.66, ONC=5, SE CV=0.61, r 2=0.95, SE non-CV=0.24, F(5, 30)=107), consisting of the training set plus the test set of compounds, may prove useful in the design of new phenoxypropanolamine type β 1-AR antagonists. The initial rat β 1-AR model ( n=26, q 2=0.42, ONC=6, SE CV=0.76, r 2=0.94, SE non-CV=0.25, F(6, 19)=47) predicted the affinities of five out of six test compounds with residual p A 2 values ≤0.50. The final rat β 1-AR model (i.e. training set plus test set of compounds) ( n=32, q 2=0.38, ONC=5, SE CV=0.69, r 2=0.93, SE non-CV=0.24, F(5, 26)=67) in particular has a low q 2 value, indicating that, at least for the rat, the biologically active phenoxypropanolamine conformation may be quite different to the low energy extended conformation chosen for this CoMFA study.
Read full abstract